Adaptimmune and Cryoport Announce Agreement to Ensure Safe and Fully Monitored Transport of Adaptimmune’s Cell Therapies Read more
Ionis’ Factor XI anti-thrombotic medicine advances with Bayer following positive clinical results Read more
bluebird bio and Novo Nordisk Enter into Research Agreement to Develop in vivo Genome Editing Candidates for Haemophilia and Other Severe Genetic Diseases Read more
Hoth Therapeutics Successfully Completes Phase I of In-Life Dose Escalation Study for Treating Eczema Read more
Novartis receives FDA approval for Beovu, offering wet AMD patients vision gains and greater fluid reductions vs aflibercept Read more
GSK and Lyell Immunopharma join forces to develop the next generation of cancer cell therapies Read more